These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9242960)

  • 1. von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia.
    Blann AD; Miller JP; McCollum CN
    Atherosclerosis; 1997 Jul; 132(2):151-6. PubMed ID: 9242960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to lipids and vascular disease.
    Blann AD; Davis A; Miller JP; McCollum CN
    Am J Hematol; 1997 May; 55(1):15-23. PubMed ID: 9136912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis.
    Blann AD; Waite MA
    Coron Artery Dis; 1996 Feb; 7(2):143-7. PubMed ID: 8813446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of the TGF-beta receptor are increased in atherosclerosis.
    Blann AD; Wang JM; Wilson PB; Kumar S
    Atherosclerosis; 1996 Feb; 120(1-2):221-6. PubMed ID: 8645363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease: relationship with von Willebrand factor.
    Blann AD; Goode GK; Miller JP; McCollum CN
    Blood Coagul Fibrinolysis; 1997 Apr; 8(3):200-4. PubMed ID: 9167022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension.
    Blann AD; Tse W; Maxwell SJ; Waite MA
    J Hypertens; 1994 Aug; 12(8):925-8. PubMed ID: 7529277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers of endothelial activation in primary hyperparathyroidism.
    Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
    Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
    Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
    Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients.
    Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E
    Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble adhesion molecule E-selectin predicts cardiovascular events in Japanese patients with type 2 diabetes mellitus.
    Matsumoto K; Fujishima K; Moriuchi A; Saishoji H; Ueki Y
    Metabolism; 2010 Mar; 59(3):320-4. PubMed ID: 20004427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis.
    Blann AD; McCollum CN
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):375-80. PubMed ID: 10493219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals.
    Blann AD; McCollum CN; Lip GY
    Blood Coagul Fibrinolysis; 2002 Sep; 13(6):513-8. PubMed ID: 12192303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
    Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
    Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease.
    Blann AD; Seigneur M; Steiner M; Boisseau MR; McCollum CN
    Eur J Clin Invest; 1997 Nov; 27(11):916-21. PubMed ID: 9395787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria.
    Gaede P; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2001 Oct; 16(10):2028-33. PubMed ID: 11572892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease.
    Heitmar R; Lip GYH; Ryder RE; Blann AD
    Cardiovasc Diabetol; 2017 Apr; 16(1):56. PubMed ID: 28446234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.